Ilyang Pharmaceutical Co.,Ltd - Asset Resilience Ratio

Latest as of June 2026: 1.08%

Ilyang Pharmaceutical Co.,Ltd (007575) has an Asset Resilience Ratio of 1.08% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 007575 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩4.87 Billion

≈ $3.30 Million USD Cash + Short-term Investments

Total Assets

₩451.72 Billion

≈ $306.13 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Ilyang Pharmaceutical Co.,Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 007575 total assets.

Liquid Assets Composition Over Time

This chart breaks down Ilyang Pharmaceutical Co.,Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Ilyang Pharmaceutical Co.,Ltd (007575) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩4.87 Billion	1.08%
Total Liquid Assets	₩4.87 Billion	1.08%

Asset Resilience Insights

Limited Liquidity: Ilyang Pharmaceutical Co.,Ltd maintains only 1.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Ilyang Pharmaceutical Co.,Ltd Industry Peers by Asset Resilience Ratio

Compare Ilyang Pharmaceutical Co.,Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Ilyang Pharmaceutical Co.,Ltd (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Ilyang Pharmaceutical Co.,Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.31%	₩5.97 Billion ≈ $4.05 Million	₩457.33 Billion ≈ $309.93 Million	-0.66pp
2024-12-31	1.97%	₩8.49 Billion ≈ $5.76 Million	₩431.03 Billion ≈ $292.10 Million	+0.07pp
2023-12-31	1.90%	₩6.78 Billion ≈ $4.59 Million	₩356.66 Billion ≈ $241.70 Million	+0.81pp
2022-12-31	1.09%	₩5.42 Billion ≈ $3.67 Million	₩498.19 Billion ≈ $337.61 Million	-5.86pp
2021-12-31	6.95%	₩34.34 Billion ≈ $23.27 Million	₩494.27 Billion ≈ $334.96 Million	+6.89pp
2020-12-31	0.06%	₩270.87 Million ≈ $183.56K	₩439.12 Billion ≈ $297.58 Million	+0.05pp
2019-12-31	0.01%	₩43.52 Million ≈ $29.49K	₩437.46 Billion ≈ $296.46 Million	-1.25pp
2018-12-31	1.26%	₩5.46 Billion ≈ $3.70 Million	₩432.25 Billion ≈ $292.93 Million	+0.51pp
2017-12-31	0.76%	₩3.31 Billion ≈ $2.24 Million	₩436.37 Billion ≈ $295.72 Million	+0.75pp
2016-12-31	0.01%	₩43.85 Million ≈ $29.72K	₩431.26 Billion ≈ $292.26 Million	-0.07pp
2015-12-31	0.08%	₩354.85 Million ≈ $240.48K	₩431.63 Billion ≈ $292.51 Million	-0.05pp
2014-12-31	0.13%	₩581.48 Million ≈ $394.06K	₩430.83 Billion ≈ $291.97 Million	--

pp = percentage points

About Ilyang Pharmaceutical Co.,Ltd

KO:007575 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$92.33 Million

₩136.24 Billion KRW

Market Cap Rank

#19573 Global

#993 in Korea

Share Price

₩7500.00

Change (1 day)

+0.94%

52-Week Range

₩7000.00 - ₩12980.00

All Time High

₩141909.13